NCT06150365View on ClinicalTrials.gov

Personalized KSX01-TCRT in Patients With Advanced Solid Tumors

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 7, 2023

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2028

Conditions
Refractory Solid TumorsRelapsed Solid Tumors
Interventions
BIOLOGICAL

KSX01-TCRT cell therapy

Patient autologous T cell therapy

Trial Locations (1)

Unknown

RECRUITING

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors
lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER